Boston Angel Investors →
Founder and CEO of Brooks Bell Inc.
CEO of Zero Locus
Partner, Third Rock Ventures
Founder and CEO, Lighter Capital
Managing Director, D.E. Shaw and Co., L.P.
Founder, Young Inventors
Founder and Managing Partner, Frazier Healthcare Ventures
September 30, 2015 ·
October 30, 2015 ·
Ascent Therapeutics, based in Cambridge, MA, is developing a new class of drugs to target cell surface receptors involved in many diseases.
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin and beyond.
© 2007-2015, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.